Analysis of 3 independent RA patients showed that Upa treatment results in significantly diminished levels of the classical CD14 + + CD16- monocyte subset and an augmented proportion of non-classical CD14 + CD16 + monocytes (Fig. 1A–B and Supplementary Fig. 1). The gene discussed is CD14; the disease is rheumatoid arthritis.